DekaBank Deutsche Girozentrale Increases Stock Holdings in Clorox Co (NYSE:CLX)

Share on StockTwits

DekaBank Deutsche Girozentrale increased its holdings in shares of Clorox Co (NYSE:CLX) by 4.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 445,215 shares of the company’s stock after buying an additional 18,202 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in Clorox were worth $67,858,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also made changes to their positions in the stock. BlackRock Inc. grew its stake in Clorox by 0.8% during the 1st quarter. BlackRock Inc. now owns 10,639,351 shares of the company’s stock valued at $1,707,189,000 after purchasing an additional 83,514 shares during the last quarter. Northern Trust Corp grew its stake in Clorox by 3.4% during the 1st quarter. Northern Trust Corp now owns 2,355,067 shares of the company’s stock valued at $377,894,000 after purchasing an additional 76,799 shares during the last quarter. Geode Capital Management LLC grew its stake in Clorox by 21.5% during the 4th quarter. Geode Capital Management LLC now owns 1,899,544 shares of the company’s stock valued at $292,347,000 after purchasing an additional 335,835 shares during the last quarter. Janus Henderson Group PLC grew its stake in Clorox by 1.9% during the 2nd quarter. Janus Henderson Group PLC now owns 1,804,217 shares of the company’s stock valued at $276,243,000 after purchasing an additional 33,032 shares during the last quarter. Finally, Swiss National Bank grew its stake in Clorox by 2.6% during the 1st quarter. Swiss National Bank now owns 912,292 shares of the company’s stock valued at $146,386,000 after purchasing an additional 22,900 shares during the last quarter. Hedge funds and other institutional investors own 77.01% of the company’s stock.

In other Clorox news, Director A D. David Mackay sold 3,400 shares of the stock in a transaction that occurred on Tuesday, August 6th. The stock was sold at an average price of $154.87, for a total transaction of $526,558.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Diego J. Barral sold 1,987 shares of the stock in a transaction that occurred on Friday, August 2nd. The shares were sold at an average price of $157.59, for a total value of $313,131.33. The disclosure for this sale can be found here. Insiders sold a total of 25,786 shares of company stock valued at $4,054,776 in the last ninety days. 1.40% of the stock is currently owned by insiders.

Several research firms have weighed in on CLX. ValuEngine downgraded Clorox from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Royal Bank of Canada boosted their price target on Clorox to $161.00 and gave the company a “sector perform” rating in a research note on Friday, August 2nd. Wells Fargo & Co reiterated a “hold” rating and set a $153.00 price target on shares of Clorox in a research note on Thursday, August 1st. Bank of America reiterated a “neutral” rating and set a $154.00 price target (down previously from $165.00) on shares of Clorox in a research note on Thursday, May 2nd. Finally, Morgan Stanley boosted their price objective on Clorox from $141.00 to $144.00 and gave the company an “underweight” rating in a report on Friday, August 2nd. Three equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have issued a buy rating to the company. Clorox has a consensus rating of “Hold” and a consensus price target of $154.07.

Shares of CLX stock opened at $158.96 on Wednesday. The firm has a market cap of $20.20 billion, a PE ratio of 25.15, a PEG ratio of 4.98 and a beta of 0.37. The company has a 50-day moving average of $158.36. The company has a current ratio of 0.91, a quick ratio of 0.55 and a debt-to-equity ratio of 4.09. Clorox Co has a 52-week low of $140.82 and a 52-week high of $167.70.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Thursday, August 1st. The company reported $1.88 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.84 by $0.04. The business had revenue of $1.63 billion during the quarter, compared to analysts’ expectations of $1.69 billion. Clorox had a return on equity of 118.88% and a net margin of 13.20%. The company’s revenue for the quarter was down 3.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.66 EPS. As a group, research analysts expect that Clorox Co will post 6.4 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 16th. Investors of record on Wednesday, July 31st will be issued a $1.06 dividend. This is a boost from Clorox’s previous quarterly dividend of $0.96. The ex-dividend date of this dividend is Tuesday, July 30th. This represents a $4.24 dividend on an annualized basis and a yield of 2.67%. Clorox’s dividend payout ratio is presently 67.09%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Featured Article: What does cost of debt say about a company’s financial health?

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

EJF Capital LLC Lowers Stake in Sandy Spring Bancorp Inc.
EJF Capital LLC Lowers Stake in Sandy Spring Bancorp Inc.
EJF Capital LLC Buys New Position in Radian Group Inc
EJF Capital LLC Buys New Position in Radian Group Inc
EJF Capital LLC Has $7.26 Million Position in Rhinebeck Bancorp Inc
EJF Capital LLC Has $7.26 Million Position in Rhinebeck Bancorp Inc
EJF Capital LLC Buys Shares of 402,288 Mainstreet Bank Common Stock
EJF Capital LLC Buys Shares of 402,288 Mainstreet Bank Common Stock
EJF Capital LLC Grows Stock Position in First Savings Financial Group Inc
EJF Capital LLC Grows Stock Position in First Savings Financial Group Inc
SB Financial Group Inc  Shares Bought by EJF Capital LLC
SB Financial Group Inc Shares Bought by EJF Capital LLC


© 2006-2019 Ticker Report